Stem client Hissey Kientz LLP has launched a microsite detailing the problems faced by former patients who received a transvaginal mesh (“TVM”) patch during surgery to repair pelvic organ prolapse. The new site is located at TVMLawsuitHelp.com.

The U.S. Food and Drug Administration (FDA) has issued warnings regarding the use of transvaginal mesh, which can expose patients to a greater risk of complications than other methods of surgical vaginal repair. The FDA stated that patients undergoing mesh repair surgery could experience severe side effects such as vaginal mesh erosion and organ perforation.